Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Biagini

Showing results (81-90 of 247) with videos related to

Pageof 25
Sort By:
Orphanet Journal of Rare Diseases|September 2, 2025
Functional and histopathologic correlation in the fabry nephropathy with N215S genotypeRenzo Mignani, Gian Marco Berti, Gisella Vischini, et al.
European Journal of Heart Failure|September 28, 2005
Benefits of coronary revascularisation in diabetic and non-diabetic patients with ischaemic cardiomyopathy: role of myocardial viabilityVittoria Rizzello, Don Poldermans, Elena Biagini, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 5, 2006
Impact of diabetes mellitus on prediction of clinical outcome after coronary revascularization by 18F-FDG SPECT in patients with ischemic left ventricular dysfunctionArend F L Schinkel, Don Poldermans, Vittoria Rizzello, et al.
The American Journal of Cardiology|August 2, 2005
Relation of improvement in left ventricular ejection fraction versus improvement in heart failure symptoms after coronary revascularization in patients with ischemic cardiomyopathyVittoria Rizzello, Don Poldermans, Elena Biagini, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|June 27, 2024
The Italian Fabry Disease Cardiovascular Registry (IFDCR)Giuseppe Limongelli, Elena Biagini, Francesco Cappelli, et al.
The American Journal of Cardiology|May 5, 2007
Prognostic significance of myocardial ischemia during dobutamine stress echocardiography in asymptomatic patients with diabetes mellitus and no prior history of coronary eventsFabiola B Sozzi, Abdou Elhendy, Vittoria Rizzello, et al.
JAMA Cardiology|August 10, 2017
Intraoperative Diagnosis of Anderson-Fabry Disease in Patients With Obstructive Hypertrophic Cardiomyopathy Undergoing Surgical MyectomyFranco Cecchi, Maria Iascone, Niccolò Maurizi, et al.
The American Journal of Cardiology|December 8, 2009
Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathyElena Biagini, Paolo Spirito, Guido Rocchi, et al.
Journal of the American College of Cardiology|September 6, 2005
Prognostic significance of left anterior hemiblock in patients with suspected coronary artery diseaseElena Biagini, Abdou Elhendy, Arend F L Schinkel, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 3, 2023
A cost-effectiveness analysis of hypertrophic cardiomyopathy sudden cardiac death risk algorithms for implantable cardioverter defibrillator decision-makingNathan Green, Yang Chen, Constantinos O'Mahony, et al.
Pageof 25

Showing results (81-90 of 247) with videos related to

Sort By:
Pageof 25
Orphanet Journal of Rare Diseases|September 2, 2025
Functional and histopathologic correlation in the fabry nephropathy with N215S genotypeRenzo Mignani, Gian Marco Berti, Gisella Vischini, et al.
European Journal of Heart Failure|September 28, 2005
Benefits of coronary revascularisation in diabetic and non-diabetic patients with ischaemic cardiomyopathy: role of myocardial viabilityVittoria Rizzello, Don Poldermans, Elena Biagini, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 5, 2006
Impact of diabetes mellitus on prediction of clinical outcome after coronary revascularization by 18F-FDG SPECT in patients with ischemic left ventricular dysfunctionArend F L Schinkel, Don Poldermans, Vittoria Rizzello, et al.
The American Journal of Cardiology|August 2, 2005
Relation of improvement in left ventricular ejection fraction versus improvement in heart failure symptoms after coronary revascularization in patients with ischemic cardiomyopathyVittoria Rizzello, Don Poldermans, Elena Biagini, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|June 27, 2024
The Italian Fabry Disease Cardiovascular Registry (IFDCR)Giuseppe Limongelli, Elena Biagini, Francesco Cappelli, et al.
The American Journal of Cardiology|May 5, 2007
Prognostic significance of myocardial ischemia during dobutamine stress echocardiography in asymptomatic patients with diabetes mellitus and no prior history of coronary eventsFabiola B Sozzi, Abdou Elhendy, Vittoria Rizzello, et al.
JAMA Cardiology|August 10, 2017
Intraoperative Diagnosis of Anderson-Fabry Disease in Patients With Obstructive Hypertrophic Cardiomyopathy Undergoing Surgical MyectomyFranco Cecchi, Maria Iascone, Niccolò Maurizi, et al.
The American Journal of Cardiology|December 8, 2009
Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathyElena Biagini, Paolo Spirito, Guido Rocchi, et al.
Journal of the American College of Cardiology|September 6, 2005
Prognostic significance of left anterior hemiblock in patients with suspected coronary artery diseaseElena Biagini, Abdou Elhendy, Arend F L Schinkel, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 3, 2023
A cost-effectiveness analysis of hypertrophic cardiomyopathy sudden cardiac death risk algorithms for implantable cardioverter defibrillator decision-makingNathan Green, Yang Chen, Constantinos O'Mahony, et al.
Pageof 25